Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 2
2008 3
2009 4
2010 8
2011 8
2012 7
2013 7
2014 13
2015 13
2016 6
2017 15
2018 12
2019 14
2020 15
2021 21
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.
Yao Y, Chen Z, Zhang H, Chen C, Zeng M, Yunis J, Wei Y, Wan Y, Wang N, Zhou M, Qiu C, Zeng Q, Ong HS, Wang H, Makota FV, Yang Y, Yang Z, Wang N, Deng J, Shen C, Xia Y, Yuan L, Lian Z, Deng Y, Guo C, Huang A, Zhou P, Shi H, Zhang W, Yi H, Li D, Xia M, Fu J, Wu N, de Haan JB, Shen N, Zhang W, Liu Z, Yu D. Yao Y, et al. Among authors: qiu c. Nat Immunol. 2021 Sep;22(9):1127-1139. doi: 10.1038/s41590-021-00996-0. Epub 2021 Aug 19. Nat Immunol. 2021. PMID: 34413521
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
Ai J, Zhang H, Zhang Y, Lin K, Zhang Y, Wu J, Wan Y, Huang Y, Song J, Fu Z, Wang H, Guo J, Jiang N, Fan M, Zhou Y, Zhao Y, Zhang Q, Liu Q, Lv J, Li P, Qiu C, Zhang W. Ai J, et al. Among authors: qiu c. Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440. Emerg Microbes Infect. 2022. PMID: 34935594 Free PMC article.
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy.
Sun Y, Wu X, Zhou J, Meng T, Wang B, Chen S, Liu H, Wang T, Zhao X, Wu S, Kong Y, Ou X, Wee A, Theise ND, Qiu C, Zhang W, Lu F, Jia J, You H. Sun Y, et al. Among authors: qiu c. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2582-2591.e6. doi: 10.1016/j.cgh.2020.03.001. Epub 2020 Mar 6. Clin Gastroenterol Hepatol. 2020. PMID: 32147592 Free article.
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
Wu X, Li N, Wang G, Liu W, Yu J, Cao G, Wang J, Chen Y, Ma J, Wu J, Yang H, Mao X, He J, Yu Y, Qiu C, Li N, Yao S, Feng H, Yan J, Zhang W, Zhang J. Wu X, et al. Among authors: qiu c. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0035021. doi: 10.1128/AAC.00350-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 33972256 Free PMC article. Clinical Trial.
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.
Ai J, Zhang H, Zhang Q, Zhang Y, Lin K, Fu Z, Song J, Zhao Y, Fan M, Wang H, Qiu C, Zhou Y, Zhang W. Ai J, et al. Among authors: qiu c. Cell Res. 2022 Jan;32(1):103-106. doi: 10.1038/s41422-021-00590-x. Epub 2021 Nov 23. Cell Res. 2022. PMID: 34815511 Free PMC article. No abstract available.
The Association of Human Leukocyte Antigen and COVID-19 in Southern China.
Yu X, Ho K, Shen Z, Fu X, Huang H, Wu D, Lin Y, Lin Y, Chen W, Su M, Qiu C, Zhuang X, Su Z. Yu X, et al. Among authors: qiu c. Open Forum Infect Dis. 2021 Aug 6;8(9):ofab410. doi: 10.1093/ofid/ofab410. eCollection 2021 Sep. Open Forum Infect Dis. 2021. PMID: 34552996 Free PMC article.
146 results